Table 1.

Primary and secondary outcomes. “X” indicates that this outcome was assessed at the time point indicated in the column above. VS: viral suppression. VL: viral load. CASI: computer-assisted self-interviewing. ART: antiretroviral therapy.

Outcome		Source	13 weeks	26 weeks	39 weeks	Description
Primary study outcomes
	VS defined as VL below the lower limit of detection in the 6-week window before the scheduled study visits	Chart review (any value in 6-week window before scheduled visit) OR laboratory value collected at study visit	X	X		<40 copies/mL or lower limit of detection for site-specific assay used to test the specimen
Secondary study outcomes
	VL suppression defined as VL below the lower limit of detection in the 6-week window before the scheduled study visits	Chart review (any value in 6-week window before scheduled visit) OR laboratory value collected at study visit			X	<40 copies/mL or lower limit of detection for site-specific assay used to test the specimen
	Engagement in care	CASI survey	X	X	X	Completion of HIV-related care clinic visit in last 3 months
	ART uptake (for participants not on ART)	CASI survey	X	X	X	“Are you currently taking medication to treat your HIV (Y/N)?”
	ART adherencea (for participants on ART)	CASI survey	X	X	X	(1) “How many times during the day has your doctor told you to take a dose of medicine (pills or other medicines) to treat your HIV?” and (2) “Thinking about the last 7 days, how many times did you miss taking a dose of pills?”[64]

^aOutcome of >90% adherence is comprised 2 components (1) is the denominator, indicating the frequency of doses prescribed (multiplied x7 to represent total weekly doses); (2) is the numerator, indicating the number of times, total, a dose was missed.